Adrenal and gonadal function in obesity

Journal of Endocrinological Investigation

Volumn 25, Issue 10, 2002, Pages 893-898

  Pasquali, Renato ^a   Vicennati, V ^a   Gambineri, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Abdominal obesity; Androgens; Estrogens; Hypothalamic pituitary adrenal axis

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; ANTIANDROGEN; CORTICOSTEROID; DEXAMETHASONE; ESTROGEN; FLUTAMIDE; HYDROCORTISONE; INSULIN; LUTEINIZING HORMONE; METFORMIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; XENOBIOTIC AGENT; CORTICOSTERONE;

ABDOMEN; ADIPOSE TISSUE; ADRENAL FUNCTION; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DISORDERS OF HORMONE METABOLISM; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; ENDOCRINE SYSTEM; FEMALE; GONAD FUNCTION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE METABOLISM; HORMONE SUBSTITUTION; HORMONE TRANSPORT; HUMAN; HYPERANDROGENISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESPONSE; LIPOHYPERTROPHY; LUTEINIZING HORMONE RELEASE; MALE; MENOPAUSAL SYNDROME; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; SEX DIFFERENCE; TESTOSTERONE RELEASE; VISCERA; ADRENAL GLAND; ANIMAL; METABOLISM; SEXUAL DEVELOPMENT;

ADIPOSE TISSUE; ADRENAL GLANDS; ANIMALS; CORTICOSTERONE; GONADAL STEROID HORMONES; HUMANS; HYDROCORTISONE; OBESITY; SEX CHARACTERISTICS;

EID: 0036860389     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344053     Document Type: Review

References (32)

1. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocr. Rev. 2000, 21: 697-738.
2. Pasquali R., Vicennati V. Obesity and hormonal abnormalities. In: International Textbook of Obesity. 2001, p. 225.
3. Björntorp P. The regulation of adipose tissue distribution in humans. Int. J. Obes. 1996, 20: 291-302.
4. Smith S.R. The endocrinology of obesity. Endocr. Metab. Clin. North Am. 1996, 25: 921-942.
5. Pasquali R., Vicennati V. The abdominal obesity phenotype and insulin resistance are associated with abnormalities of the hypothalamic-pituitary-adrenal axis in humans. Horm. Metab. Res. 2000, 32: 521-525.
6. Björntorp P. Centralization of body fat. In: Björntorp P., International Textbook of Obesity. John Wiley & Sons, Chichester, 2001, p. 213.
7. Pasquali R., Biscotti D., Spinucci G. et al. Pulsatile secretion of ACTH and cortisol in pre-menopausal women: Effect of obesity and body fat distribution. Clin. Endocrinol. (Oxf.) 1998, 48: 603-612.
8. Vicennati V., Ceroni L., Gagliardi L., Gambineri A., Pasquali R. Response of the hypothalamic-pituitary-adrenocortical axis to high protein-fat and high carbohydrate meals in women with different obesity phenotypes. J. Clin. Endocrinol. Metab. 2002, 87, (In press).
9. Rosmond R., Dallman M.F., Bjorntorp P. Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 1998, 83: 1853-1859.
10. Pasquali R., Ambrosi B., Armanini D. et al., on the behalf of the "Study Group on Obesity" of the Italian Society of Endocrinology. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution and dexamethasone concentrations: A dose-response study. J. Clin. Endocrinol. Metab. 2002, 87: 166-175.
11. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998, 19: 269-301.
12. Jessop D., Dallman M.F., Fleming D., Lightman S.L. Resistance to glucocorticoid feedback in obesity. J. Clin. Endocrinol. Metab. 2001, 86: 4109-4114.
13. Dallman M.F., Bhatnagar S. Chronic stress and energy balance: Role of the hypothalamic-pituitary-adrenal axis. In: Mc Ewen BS (Ed.), Handbook of Physiology, The Environment. Am. Physiol. Soc. Washington, D.C., 1998.
14. Shively C., Clarkson T. Regional obesity and coronary atherosclerosis in females: A non-human primate model. Acta Med. Scand. 1989, 723 (Suppl.) 71-78.
15. Rebuffé-Scrive M., Lundholm K., Björntorp P. Glucocorticoid hormone binding to human adipose tissue. Eur. J. Clin. Invest. 1985, 15: 267-271.
16. Sandeep T.C., Walker B.R. Pathophysiology of modulation of local glucocorticoid levels by 11β-hydrooxysteroid dehydrogenase. Trends Endocrinol. Metab. 2002, 12: 466-453.
17. Resk E., Olsson T., Doderberg S. et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J. Clin. Endocrinol. Metab. 2001, 86: p. 1418.
18. Masuzaki H., Paterson J., Shinyama H. et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294: 2166-2170.
19. Gambineri A, Pelusi C, Vicennati V., Pagotto U., Pasquali R. Obesity and the polycystic ovary syndrome. Int. J. Obes. 2002, 26: 883-896.
20. Frank S. Polycystic ovary syndrome. N. Engl. J. Med. 1995, 333: 853-861.
21. Samojlik E., Kirschner M.A., Silber D., Schneider G., Ertel N.H. Elevated production and metabolic clearance rates of androgens in morbidly obese women. J. Clin. Endocrinol. Metab. 1984, 59: 949-954.
22. Kirschner M.A., Samojlik E., Drejka M., Szmal E., Schneider G., Ertel N. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J. Clin. Endocrinol. Metab. 1990, 70: 473-479.
23. Lovejoy J.C., Bray G.A., Bourgeois M.O. et al. Exogenous androgens influence body composition and regional body fat distribution in obese post-menopausal women - A clinical research center study. J. Clin. Endocrinol. Metab. 1996, 81: 2198-2203.
24. Gambineri A., Pelusi C, Vicennati V., Pagotto U., Pasquali R. Flutamide (F) and metformin (M) added to low-calorie diet (LCD) in the treatment obf obese women with polycystic ovary syndrome (PCOS): A clinical study. The Endocrine Society 84th Meeting, San Francisco, 2002 (abs.).
25. Poretsky L., Cataldo N.A., Rosenwaks Z., Giudice L.C. The insulin-related ovarian regulatory system in health and disease. Endocr. Rev. 1999, 20: 535-582.
26. Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr. Rev. 1997; 18: 774-800.
27. Pasquali R., Casimirri F. The impact of obesity on hyperandrogenism and polycystic ovary in premenopausal women. Clin. Endocrinol. (Oxf.) 1993; 39: 1-16.
28. Zumoff B., Strain G., Miller L.K. et al. Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J. Clin. Endocrinol. Metab. 1990, 71: 929-931.
29. Tchernoff A., Després J.P., Bélanger A. et al. Reduced testosterone and adrenal C19 steroid levels in obese women. Metabolism 1995, 44: 513-519.
30. Vermuelen A., Kaufman J.M., Deslypere J.P., Thomas G. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J. Clin. Endocrinol. Metab. 1993, 76: 1140-1146.
31. Marin P., Holmang S., Jonsson L. et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int. J. Obes. 1992, 16: 991-997.
32. Marin P., Oden B., Björntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: Effects of androgens. J. Clin. Endocrinol. Metab. 1995, 80: 239-243.